Abstract
Stroke is the most common life-threatening neurological disease and is the fourth leading cause of death among adult Canadians. Aspirin is the most frequently prescribed antithrombotic drug to prevent stroke but may not be a suitable choice in older patients who have already had stroke symptoms despite its use, or cannot tolerate its side effects. For these patients, clopidogrel or the combination of low-dose aspirin with extended release (ER) dipyridamole should be considered for prevention of stroke, This review will compare the relative benefits of aspirin, clopidogrel, and low-dose aspirin/ER-dipyridamole in geriatric patients at risk for stroke.
| Original language | English |
|---|---|
| Pages (from-to) | 15-19 |
| Number of pages | 5 |
| Journal | Geriatrics and Aging |
| Volume | 7 |
| Issue number | 8 |
| State | Published - Sep 2004 |
Keywords
- Aspirin
- Clopidogrel
- Dipyridamole
- Myocardial infarction
- Stroke
ASJC Scopus subject areas
- Aging
- Gerontology
- Geriatrics and Gerontology
Fingerprint
Dive into the research topics of 'Medical therapy for stroke prevention in the older patient: What to do when aspirin isn't enough'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver